ClinicalTrials.gov
ClinicalTrials.gov Menu

PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00116792
Recruitment Status : Unknown
Verified May 2007 by Gold, Herman K., MD.
Recruitment status was:  Active, not recruiting
First Posted : July 1, 2005
Last Update Posted : May 17, 2007
Sponsor:
Collaborator:
Guidant Corporation
Information provided by:
Gold, Herman K., MD

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given